These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6981695)

  • 1. Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin.
    Nolan G; Moivor P; Levison H; Fleming PC; Corey M; Gold R
    J Pediatr; 1982 Oct; 101(4):626-30. PubMed ID: 6981695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Smyth AR; Walters S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD001912. PubMed ID: 23235585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic antibiotics for cystic fibrosis.
    Smyth A; Walters S
    Cochrane Database Syst Rev; 2003; (3):CD001912. PubMed ID: 12917916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic antibiotics for cystic fibrosis.
    Smyth A; Walters S
    Cochrane Database Syst Rev; 2000; (2):CD001912. PubMed ID: 10796836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
    Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
    J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.
    Bauernfeind A; Bertele RM; Harms K; Hörl G; Jungwirth R; Petermüller C; Przyklenk B; Weisslein-Pfister C
    Infection; 1987; 15(4):270-7. PubMed ID: 3117700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis: infection.
    Høiby N
    Schweiz Med Wochenschr; 1991 Jan; 121(4):105-9. PubMed ID: 1900640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients.
    Bauernfeind A; Hörl G; Przyklenk B
    Scand J Gastroenterol Suppl; 1988; 143():99-102. PubMed ID: 3164518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review of antistaphylococcal antibiotic therapy in cystic fibrosis.
    McCaffery K; Olver RE; Franklin M; Mukhopadhyay S
    Thorax; 1999 May; 54(5):380-3. PubMed ID: 10212099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic antibiotics in cystic fibrosis: a conviction without evidence?
    Smyth A
    Pediatr Pulmonol; 2005 Dec; 40(6):471-6. PubMed ID: 16200640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective media for the quantitation of bacteria in cystic fibrosis sputum.
    Wong K; Roberts MC; Owens L; Fife M; Smith AL
    J Med Microbiol; 1984 Apr; 17(2):113-9. PubMed ID: 6423825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis?
    Beaudry PH; Marks MI; McDougall D; Desmond K; Rangel R
    J Pediatr; 1980 Jul; 97(1):144-7. PubMed ID: 7381634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc Supplementation for One Year Among Children with Cystic Fibrosis Does Not Decrease Pulmonary Infection.
    Sharma G; Lodha R; Shastri S; Saini S; Kapil A; Singla M; Mukherjee A; Jat KR; Kabra M; Kabra SK
    Respir Care; 2016 Jan; 61(1):78-84. PubMed ID: 26443019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
    Hoiby N
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):541-50. PubMed ID: 4153350
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathogenesis and diagnosis of bacterial airway infections in patients with cystic fibrosis].
    Möller AV; van Alphen L; Dankert-Roelse JE; Dankert J
    Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2346-9. PubMed ID: 7501072
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.